Stay updated with breaking news from Nasdaq Podd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Insulet (NASDAQ:PODD – Get Rating) had its price objective boosted by Piper Sandler from $340.00 to $360.00 in a report issued on Friday, The Fly reports. Other equities research analysts have also issued reports about the stock. Wolfe Research started coverage on shares of Insulet in a report on Thursday, January 26th. They set a […]
Insulet (NASDAQ:PODD – Get Rating) had its target price upped by Robert W. Baird from $350.00 to $370.00 in a report published on Friday morning, The Fly reports. A number of other analysts have also recently commented on PODD. Stifel Nicolaus upped their price objective on Insulet from $300.00 to $342.00 and gave the company […]
Insulet (NASDAQ:PODD – Get Rating) had its price objective increased by equities researchers at UBS Group from $328.00 to $360.00 in a research note issued on Friday, The Fly reports. UBS Group’s target price would indicate a potential upside of 9.50% from the stock’s previous close. Several other analysts also recently weighed in on the […]
Insulet (NASDAQ:PODD – Get Rating) released its quarterly earnings results on Thursday. The medical instruments supplier reported $0.23 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.09 by $0.14, Briefing.com reports. The company had revenue of $358.10 million during the quarter, compared to the consensus estimate of $330.21 million. Insulet had […]
Insulet (NASDAQ:PODD – Get Rating) posted its quarterly earnings results on Thursday. The medical instruments supplier reported $0.23 earnings per share for the quarter, topping analysts’ consensus estimates of $0.09 by $0.14, Briefing.com reports. Insulet had a net margin of 0.35% and a return on equity of 20.55%. The firm had revenue of $358.10 million […]